Adma Biologics Stock Volatility Indicators Average True Range

ADMA Stock  USD 17.30  0.29  1.70%   
ADMA Biologics volatility indicators tool provides the execution environment for running the Average True Range indicator and other technical functions against ADMA Biologics. ADMA Biologics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volatility indicators indicators. As with most other technical indicators, the Average True Range indicator function is designed to identify and follow existing trends. ADMA Biologics volatility indicators enable investors to predict price movements based on how different True Range indicators change over time. Please specify Time Period to run this model.

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ADMA Biologics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

ADMA Biologics Technical Analysis Modules

Most technical analysis of ADMA Biologics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ADMA from various momentum indicators to cycle indicators. When you analyze ADMA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About ADMA Biologics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ADMA Biologics. We use our internally-developed statistical techniques to arrive at the intrinsic value of ADMA Biologics based on widely used predictive technical indicators. In general, we focus on analyzing ADMA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ADMA Biologics's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of ADMA Biologics's intrinsic value. In addition to deriving basic predictive indicators for ADMA Biologics, we also check how macroeconomic factors affect ADMA Biologics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2025 2026 (projected)
Dividend Yield0.07810.0694
Price To Sales Ratio10.7811.31
Hype
Prediction
LowEstimatedHigh
13.9817.0120.04
Details
Intrinsic
Valuation
LowRealHigh
10.8313.8618.71
Details
Naive
Forecast
LowNextHigh
13.1116.1419.16
Details
3 Analysts
Consensus
LowTargetHigh
23.3625.6728.49
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 20 shares
Blockchain Idea
Blockchain
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 60 shares
Advertising Idea
Advertising
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 20 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Momentum Idea
Momentum
Invested over 30 shares
When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADMA Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ADMA Biologics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
0.86
Revenue Per Share
2.053
Quarterly Revenue Growth
0.12
Return On Assets
0.2176
Return On Equity
0.6317
ADMA Biologics's market price often diverges from its book value, the accounting figure shown on ADMA's balance sheet. Smart investors calculate ADMA Biologics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ADMA Biologics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that ADMA Biologics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ADMA Biologics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.